Randox Laboratories Ltd.

Randox Laboratories is a global leader in diagnostic solutions with over 40 years of expertise in clinical laboratory, molecular, and point-of-care diagnostics. The company manufactures a comprehensive portfolio including the RX Series clinical chemistry analyzers, Vivalytic molecular point-of-care systems, and Evidence Series immunoassay analyzers. Randox provides open-channel reagents covering more than 100 disease areas including autoimmune disorders, cancers, and emergency/critical care diagnostics. The company operates as the world's largest external quality assessment (EQA) provider through RIQAS and QCMD platforms, serving over 100,000 users across 145 countries. Core offerings include quality control solutions (Acusera brand), third-party diagnostic assays, molecular infectious disease controls, and QC data management software. Beyond laboratory equipment, Randox operates multiple specialized service divisions: Contract Manufacturing (OEM partnerships), CDx and Biopharma services (biomarker development), Genomics (end-to-end sequencing with in-house bioinformatics), Pathology Services (sample collection and advanced testing), Toxicology (forensic drug detection for 600+ substances), Workplace Drug and Alcohol Testing, Food Diagnostics (antimicrobial and toxin screening), and Randox Health (preventative healthcare and home testing kits). The company serves clinical laboratories, reference labs, pharmaceutical companies, food/beverage industry, workplace testing, and forensic applications globally.